OX40L contributes to pathology in a mouse model of SLE (34) and polymorphisms in OX40L (TNFSF4) are associated with several diseases where humoral immunity is known to be perturbed including SLE and RA, leading to the investigation of this pathway as a therapeutic target (105). Here, TNFSF4 is linked to systemic lupus erythematosus.